The State Fiscal Service of Ukraine (DFS) within its jurisdiction supported the proposal of the trade association APRaD (the Association of Pharmaceutical Research and Development in Ukraine) and the American Chamber of Commerce in Ukraine for the establishment of the Interdepartmental Working Group on combating illegal trafficking of drugs in Ukraine.
This is stated in the DFS official answers to joint questions from APRaD and the Chamber on “inquity” [injustice] to the government of Ukraine concerning the illegal import and sale of counterfeit drugs and medicines of dubious quality in Ukraine.
The main tasks of the Interdepartmental Working Group on combating illegal trafficking of drugs in Ukraine should be a strengthening of management and control over the import, distribution and on-line trade of medicines of unknown origin and dubious quality in Ukraine. APRaD and the Chamber consider that this working group should consist of representatives of all the interested authorities that implement the state policy in the field of quality control and safety of medicines, including medical immunobiological preparations, medical equipment and medical devices, and trafficking of narcotic drugs, psychotropic substances and precursors, combating its illegal trafficking, as well as members of the Parliament, representatives of member-companies that produce pharmaceuticals and other stakeholders.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze